Hande Demirdere, general manager of Pierre Fabre Pharma in Turkey, sheds light on the affiliate’s impressive 93 percent growth in 2017 while highlighting where to target development opportunities in the dynamic Turkish market. In this interview, the experienced General Manager discusses the advantages of diversifying strategies, Pierre Fabre's comparative advantage among traditional MNCs, and the competitive urology landscape.
What first attracted you to take on the role of general manager at Pierre Fabre?
“Last year, we grew over 90 percent in Turkey. Our Turkish affiliate was the Number Three worldwide after the US and China, based on the business growth. Not only do we grow in terms of people, revenue, and business, but crucially, margins."
